SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-009593
Filing Date
2021-07-29
Accepted
2021-07-29 16:04:47
Documents
86
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20210630x10q.htm   iXBRL 10-Q 2379571
2 EX-10.1 icpt-20210630xex10d1.htm EX-10.1 171566
3 EX-10.2 icpt-20210630xex10d2.htm EX-10.2 174718
4 EX-31.1 icpt-20210630xex31d1.htm EX-31.1 9878
5 EX-31.2 icpt-20210630xex31d2.htm EX-31.2 9861
6 EX-32.1 icpt-20210630xex32d1.htm EX-32.1 10340
7 GRAPHIC icpt-20210630xex10d1001.jpg GRAPHIC 1302
  Complete submission text file 0001558370-21-009593.txt   9294498

Data Files

Seq Description Document Type Size
8 EX-101.SCH icpt-20210630.xsd EX-101.SCH 49968
9 EX-101.CAL icpt-20210630_cal.xml EX-101.CAL 67428
10 EX-101.DEF icpt-20210630_def.xml EX-101.DEF 161490
11 EX-101.LAB icpt-20210630_lab.xml EX-101.LAB 396500
12 EX-101.PRE icpt-20210630_pre.xml EX-101.PRE 358786
13 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20210630x10q_htm.xml XML 1842330
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 211127368
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences